期刊
IBRO NEUROSCIENCE REPORTS
卷 12, 期 -, 页码 203-209出版社
ELSEVIER
DOI: 10.1016/j.ibneur.2022.03.002
关键词
Huntingtin; Huntington's disease; Neurodegeneration; Post-translational modification; SUMO; SUMOylation
资金
- Brazil National Council of Scientific and Technological Development (CNPq)
- Newton Fund, ISN
- IBRO
SUMOs are proteins that regulate the functions of target substrates through a post-translational modification called SUMOylation. In addition to their physiological roles, SUMOylation has been implicated in neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's diseases. This review focuses on the role of Htt SUMOylation in cellular processes involved in the pathogenesis of HD.
Small ubiquitin-like modifiers, SUMOs, are proteins that are conjugated to target substrates and regulate their functions in a post-translational modification called SUMOylation. In addition to its physiological roles, SUMOylation has been implicated in several neurodegenerative diseases, such as Alzheimer's, Parkinson's, and Huntington's diseases (HD). HD is a neurodegenerative monogenetic autosomal dominant disorder caused by a mutation in the CAG repeat of the huntingtin (htt) gene, which expresses a mutant Htt protein more susceptible to aggregation and toxicity. Besides Htt, other SUMO ligases, enzymes, mitochondrial and autophagic components are also important for the progression of the disease. Here we review the main aspects of Htt SUMOylation and its role in cellular processes involved in the pathogenesis of HD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据